07:00 , Jul 5, 2004 |  BC Week In Review  |  Company News

DSM Biologics N.V., Nabi Biopharmaceuticals Inc. deal

NABI exercised its option to acquire exclusive worldwide distribution rights from DSM to Aloprim intravenous allopurinol. The compound is approved to control elevated uric acid levels in patients with leukemia, lymphoma and solid tumors who...
07:00 , Sep 23, 2002 |  BC Week In Review  |  Company News

Codexis management update

Codexis Inc. , Redwood City, Calif.   Business: Chemistry, Supply/Service   Hired: John Grate as VP of R&D and CTO, formerly VP of R&D at Catalytica Inc.  ...
08:00 , Jan 22, 2001 |  BC Week In Review  |  Company News

Maxygen management update

Maxygen Inc. (MAXY), Redwood City, Calif.   Business: Chemistry, Genomics   Hired: Lawrence Briscoe as CFO and SVP, formerly CFO at Catalytica Inc. ; and Pierre Pujol as VP of corporate business development, formerly co-chair...
07:00 , Aug 7, 2000 |  BC Week In Review  |  Company News

Catalytica, DSM N.V. deal

DSM will acquire CTAL's drug business for $750 million in cash, plus the assumption of debt, for a total value of about $800 million. CTAL's pharmaceutical business applies catalytic technologies and chemical processes to improve...
07:00 , Aug 2, 2000 |  BC Extra  |  Company News

DSM to acquire Catalytica's pharmaceutical business

DSM (Heerlen, the Netherlands) will acquire the drug business of Catalytica (CTAL) for $750 million plus the assumption of debt, for a total value of about $800 million. DSM, an integrated group of life science,...
07:00 , May 30, 2000 |  BC Week In Review  |  Company News

Catalytica management update

Catalytica Inc. (CTAL), Mountain View, Calif.   Business: Supply/Service   Retired: Gabriel Cipau as president, CEO and director of CTAL's Catalytica Pharmaceuticals Inc. subsidiary   Hired: Michael Thomas as president and CEO of Catalytica Pharmaceuticals...
08:00 , Jan 10, 2000 |  BC Week In Review  |  Company News

Catalytica Pharmaceuticals Inc. management update

Catalytica Pharmaceuticals Inc., Mountain View, Calif.   Business: Supply/Service   Hired: Tom Speace as SVP of strategic partnering and business development, formerly VP of corporate development and international sales and marketing at GensiaSicor Inc.  ...
07:00 , Oct 11, 1999 |  BC Week In Review  |  Company News

Catalytica, Rhone-Poulenc Rorer deal

CTAL's Catalytica Pharmaceuticals Inc. subsidiary will non-exclusively manufacture RPR's worldwide supply of Synercid injectable streptogramin antibiotic to treat certain serious bacterial infections. The product received FDA approval last month. (CTAL acquistion, B3; management, B8) Catalytica...
07:00 , Oct 11, 1999 |  BC Week In Review  |  Company News

Catalytica, Wyckoff Chemical Co. Inc. deal

CTAL completed its acquisition of Wyckoff, a manufacturer of active drug ingredients, for 4.5 million CTAL shares (see BioCentury, July 19). The business, which will operate as a division of CTAL's Catalytica Pharmaceuticals Inc. subsidiary,...
07:00 , Oct 11, 1999 |  BC Week In Review  |  Company News

Ilex management update

Ilex Oncology Inc. (ILXO), San Antonio, Texas   Business: Cancer   Hired: Al Jecminek as VP of business development and intellectual property counsel, formerly general counsel at Catalytica Inc.  ...